Spontaneous tumor lysis syndrome

Authors

  • Victoria Augustín Bandera Servicio de Medicina Interna. Hospital Costa del Sol. Marbella (Málaga). España
  • María Ángeles Villena-Ruiz Servicio de Medicina Interna. Hospital Costa del Sol. Marbella (Málaga). España
  • Francisco Granados Pacheco Servicio de Anatomía Patológica. Hospital Costa del Sol. Marbella (Málaga). España
  • Luis Robles Cabeza Servicio de Anatomía Patológica. Hospital Costa del Sol. Marbella (Málaga). España
  • Josefa Andrea Aguilar García Servicio de Medicina Interna. Hospital Costa del Sol. Marbella (Málaga). España

DOI:

https://doi.org/10.32818/reccmi.a5n2a4

Keywords:

kidney failure, hyperuricemia, tumor lysis.

Abstract

Tumor lysis syndrome is a complication that usually occurs at the beginning of antineoplastic treatment, being the cases of spontaneous appearance very rare and even less associated with solid tumors.
We present the case of a 69-year-old male with the constitutional syndrome and the presence of multiple hepatic micronodules, evolving rapidly and progressively to a spontaneous tumor lysis syndrome.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Song M, Chan CCW, Stoeckel DA. Spontaneous Tumor Lysis Syndrome in Metastatic Melanoma. World J Oncol. 2011; 2(4): 204-207. doi: https://doi.org/10.4021/wjon347w.

McBride A, Westervelt P. Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies. J Hematol Oncol. 2012; 5:75. doi: https://doi.org/10.1186/1756-8722-5-75.

Annemans L, Moeremans K, Lamotte M, Garcia Conde J, van den Berg H, Myint H et al. Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin's lymphoma in four European countries. Leuk Lymphoma. 2003; 44(1): 77-83. doi: https://doi.org/10.1080/1042819021000054661

Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004; 127(1): 3-11. doi: https://doi.org/10.1111/j.1365-2141.2004.05094.x.

Cortes J, Moore JO, Maziarz RT, Wetzler M, Craig M, Matous J et al. Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study. J Clin Oncol. 2010; 28(27): 4207-13. doi: https://doi.org/10.1200/JCO.2009.26.8896.

Durham CG, Herrington J, Seago S, Williams C, Holguin MH. From skin to spontaneous lysis: A case of spontaneous tumor lysis syndrome in metastatic melanoma. J Oncol Pharm Pract. 2018; 24(3): 221-225. doi: https://doi.org/10.1177/1078155217693425.

Takeuchi N, Miyazawa S, Ohno Z, Yoshida S, Tsukamoto T, Fujiwara M. A Case of Spontaneous Tumor Lysis Syndrome in Malignant Melanoma. World J Oncol. 2016; 7(2-3): 40-44. doi: https://doi.org/10.14740/wjon970w.

Criscuolo M, Fianchi L, Dragonetti G, Pagano L. Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency. Expert Rev Hematol. 2016; 9(2): 197-208. doi: https://doi.org/10.1586/17474086.2016.1127156.

Published

2020-08-31

How to Cite

1.
Augustín Bandera V, Villena-Ruiz M Ángeles, Granados Pacheco F, Robles Cabeza L, Aguilar García JA. Spontaneous tumor lysis syndrome. Rev Esp Casos Clin Med Intern [Internet]. 2020 Aug. 31 [cited 2024 Nov. 23];5(2):65-7. Available from: https://www.reccmi.com/RECCMI/article/view/494